TRCT
NUVA

Tower Research Capital (TRC)’s NuVasive, Inc. NUVA Stock Holding History

Tower Research Capital (TRC)’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-741
Closed -$30.8K – 6418
2023
Q2 		$30.8K Sell
741
-435
-37% -$17.9K ﹤0.01% 3001
2023
Q1 		$48K Sell
1,176
-9,113
-89% -$390K ﹤0.01% 2539
2022
Q4 		$424K Buy
10,289
+962
+10% +$38.9K 0.02% 794
2022
Q3 		$409K Buy
9,327
+5,130
+122% +$249K 0.01% 1296
2022
Q2 		$206K Sell
4,197
-1,507
-26% -$80.8K ﹤0.01% 1758
2022
Q1 		$323K Buy
5,704
+3,386
+146% +$180K ﹤0.01% 1440
2021
Q4 		$122K Sell
2,318
-2,447
-51% -$133K ﹤0.01% 2102
2021
Q3 		$285K Sell
4,765
-4,288
-47% -$264K 0.01% 1462
2021
Q2 		$613K Buy
9,053
+1,558
+21% +$106K 0.02% 1012
2021
Q1 		$492K Buy
7,495
+1,946
+35% +$117K 0.01% 1258
2020
Q4 		$313K Sell
5,549
-45,106
-89% -$2.22M 0.01% 1358
2020
Q3 		$2.46M Buy
50,655
+30,337
+149% +$1.63M 0.03% 277
2020
Q2 		$1.13M Buy
20,318
+20,276
+48,276% +$1.17M 0.05% 447
2020
Q1 		$2K Sell
42
-2,601
-98% -$174K ﹤0.01% 2673
2019
Q4 		$204K Buy
2,643
+1,119
+73% +$79K 0.02% 573
2019
Q3 		$97K Buy
1,524
+636
+72% +$39.8K 0.01% 1374
2019
Q2 		$52K Buy
888
+678
+323% +$40K ﹤0.01% 1556
2019
Q1 		$12K Sell
210
-250
-54% -$13.3K ﹤0.01% 2603
2018
Q4 		$23K Sell
460
-2,009
-81% -$121K ﹤0.01% 1847
2018
Q3 		$175K Buy
2,469
+1,533
+164% +$97.5K 0.01% 1044
2018
Q2 		$49K Sell
936
-730
-44% -$38.2K ﹤0.01% 1867
2018
Q1 		$87K Buy
1,666
+1,495
+874% +$75.8K 0.01% 1357
2017
Q4 		$10K Sell
171
-7,800
-98% -$442K ﹤0.01% 2579
2017
Q3 		$442K Buy
+7,971
New +$527K 0.04% 298
2017
Q1 		– Sell
-196
Closed -$13K – 4124
2016
Q4 		$13K Sell
196
-723
-79% -$46.6K ﹤0.01% 2493
2016
Q3 		$61K Sell
919
-4,710
-84% -$300K 0.01% 1037
2016
Q2 		$336K Buy
5,629
+5,579
+11,158% +$302K 0.03% 400
2016
Q1 		$2K Sell
50
-71
-59% -$3.22K ﹤0.01% 3479
2015
Q4 		$7K Buy
+121
New +$6.17K ﹤0.01% 2645
2015
Q3 		– Sell
-1,230
Closed -$59K – 4988
2015
Q2 		$59K Sell
1,230
-461
-27% -$21.6K 0.01% 1241
2015
Q1 		$78K Buy
+1,691
New +$78.6K 0.01% 1103
2014
Q4 		– Sell
-496
Closed -$17K – 4864
2014
Q3 		$17K Sell
496
-3
-0.6% -$107 ﹤0.01% 2448
2014
Q2 		$18K Sell
499
-102
-17% -$3.49K ﹤0.01% 1912
2014
Q1 		$23K Sell
601
-1,083
-64% -$39.8K ﹤0.01% 1761
2013
Q4 		$54K Buy
1,684
+1,676
+20,950% +$50.3K 0.01% 1325
2013
Q3 		$0 Sell
8
-192
-96% -$4.72K ﹤0.01% 4921
2013
Q2 		$5K Buy
+200
New +$4.38K ﹤0.01% 2977

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Tower Research Capital (TRC)'s NUVA Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 741 shares — an estimated $30.8K sold.

Tower Research Capital (TRC) first reported a position in NUVA in Q2 2013 and held it in 37 quarters. The position peaked at $2.46M in Q3 2020. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 741 NuVasive, Inc. shares in Q3 2023, an estimated $30.8K.
  • Tower Research Capital (TRC) first reported a position in NuVasive, Inc. in Q2 2013 and held it in 37 quarters.
  • Tower Research Capital (TRC)'s NuVasive, Inc. position peaked at $2.46M in Q3 2020.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.